H10: this regulatory report is being submitted as part of a retrospective review and remediation per d00955245 related to capa pr 56 4122.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
It was reported that the patient is deceased and the cause of death was provided as pulse electrical activity cardiac arrest.It was reported that the patient had a medical history of unstable angina, decompensated congestive heart failure, severe aortic stenosis and moderate to severe mitral regurgitation with pulmonary hypertension.The patient also had a history of recent syncope likely cardiac in etiology.The patient had been intolerant in the past of beta-blockers, spironolactone and ace inhibitor.The patient had recent heart catheterization which showed very severe native coronary artery disease.The patient had percutaneous coronary intervention of the left anterior descending artery (lad) into the left main.The patient was optimally revascularized but still had very severe diffuse disease and was likely ischemic in all coronary territories.The patient was seen by emergency personnel and had a his bundle pacer placed.The patient had chronic renal insufficiency.The patient died one day post implant of an implantable pulse generator (ipg) system.
|